Physician profile
Patrick R Barrett
NPI 1861628661
$1,186.85
in general payments reported to CMS, 2019-2025
16 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $28.09 · 2021: $130 · 2022: $32.59 · 2023: $196 · 2024: $341 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.76 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $267.28 | 2021-2024 | Exalt Model D |
| Takeda Pharmaceuticals U.S.A., INC. | $200.21 | 2019-2025 | Entyvio, Eohilia |
| Abbvie INC. | $166.60 | 2019-2025 | |
| Madrigal Pharmaceuticals | $105.68 | 2024-2025 | Rezdiffra, Resmetirom |
| Pfizer INC. | $95.34 | 2019-2021 | |
| Genzyme Corporation | $85.30 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.84 | 2019-2022 | |
| Ardelyx, INC. | $34.23 | 2023-2024 | Ibsrela |
| Celgene Corporation | $32.87 | 2023-2024 | Zeposia |
| Medtronic, INC. | $24.47 | 2023 | Interstim |
| Ironwood Pharmaceuticals, INC | $23.16 | 2023 | Linzess |
| Ferring Pharmaceuticals INC. | $18.83 | 2025 | Rebyota |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 | |
| Capsovision, INC. | $15.25 | 2025 | Capsocam Plus |
| Olympus America INC. | $14.39 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $13.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.